NCT01764893View on ClinicalTrials.gov

Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder

PHASE4TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Overactive Bladder
Interventions
OTHER

PTNS plus solifenacin

12 weekly treatments with percutaneous tibial nerve stimulation with 5 mg of solifenacin; an additional 4 weeks of solifenacin for a total of 15 weeks of study drug.

OTHER

Placebo

12 weekly treatments with percutaneous tibial nerve stimulation with placebo; an additional 4 weeks of placebo for a total of 15 weeks of placebo.

Trial Locations (1)

02472

Bay State Clinical Trials, Inc., Watertown

Sponsors
All Listed Sponsors
lead

Bay State Clinical Trials, Inc.

OTHER

NCT01764893 - Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder | Biotech Hunter | Biotech Hunter